The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome (Q30440354)

21 June 2017

1 reference

title

The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

21 June 2017

main subject

1 reference

1 reference

Blank SK

1

1 reference

21 June 2017

McCartney CR

series ordinal

2

1 reference

21 June 2017

Marshall JC

series ordinal

3

1 reference

21 June 2017

publication date

2 May 2006

1 reference

Human Reproduction Update

21 June 2017

published in

1 reference

21 June 2017

volume

12

1 reference

21 June 2017

issue

4

1 reference

21 June 2017

page(s)

351-361

1 reference

Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Metformin directly inhibits androgen production in human thecal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

The prevalence and features of the polycystic ovary syndrome in an unselected population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Opioidergic regulation of LH pulsatility in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Synchronization of augmented luteinizing hormone secretion with sleep during puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Enhanced disparity of gonadotropin secretion by estrone in women with polycystic ovarian disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Progesterone inhibition of the hypothalamic gonadotropin-releasing hormone pulse generator: evidence for varied effects in hyperandrogenemic adolescent girls

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Activation of A-type gamma-aminobutyric acid receptors excites gonadotropin-releasing hormone neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Do androgens directly regulate gonadotropin secretion in the polycystic ovary syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

The effects of the aromatase inhibitor delta 1-testolactone on gonadotropin release and steroid metabolism in polycystic ovarian disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Obese Patients with Polycystic Ovary Syndrome: Evidence that Metformin Does Not Restore Sensitivity of the Gonadotropin-Releasing Hormone Pulse Generator to Inhibition by Ovarian Steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Polycystic Ovary Syndrome as a Form of FunctionalOvarian Hyperandrogenism Due to Dysregulation ofAndrogen Secretion*

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Neuroendocrine consequences of prenatal androgen exposure in the female rat: absence of luteinizing hormone surges, suppression of progesterone receptor gene expression, and acceleration of the gonadotropin-releasing hormone pulse generator

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Negative feedback effects of gonadal steroids are preserved with aging in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

The endocrine basis of the synergistic suppression of luteinizing hormone by estradiol and progesterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Differential control of luteinizing hormone and follicle-stimulating hormone secretion by luteinizing hormone-releasing hormone pulse frequency in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Endogenous GABA release inhibits the firing of adult gonadotropin-releasing hormone neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Suppression of urinary and plasma follicle-stimulating hormone by exogenous estrogens in prepubertal and pubertal children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Obesity in children and young people: a crisis in public health

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Oestrogen modulates progestin receptor concentrations in some rat brain regions but not in others

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Metformin has direct effects on human ovarian steroidogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Gonadotropin-releasing hormone: role of pulsatile secretion in the regulation of reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Neuroendocrine aspects of polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Hypothalamic regulation of cyclic ovulation: evidence that the increase in gonadotropin-releasing hormone pulse frequency during the follicular phase reflects the gradual loss of the restraining effects of progesterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Exaggerated 17-hydroxyprogesterone response to intravenous infusions of recombinant human LH in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Luteinizing hormone secretion is not influenced by insulin infusion in women with polycystic ovary syndrome despite improved insulin sensitivity during pioglitazone treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Troglitazone: a possible modulator of ovarian steroidogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Effects of alpha 1-adrenergic blockade on pulsatile luteinizing hormone, follicle-stimulating hormone, and prolactin secretion in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Increased Luteinizing Hormone Secretion in Women with Polycystic Ovary Syndrome Is Unaltered by Prolonged Insulin Infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

The effect of sodium valproate on luteinizing hormone secretion in women with polycystic ovary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Relative changes in LH pulsatility during the menstrual cycle: using data from hypogonadal women as a reference point

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Dyslipidemia and metabolic syndrome in the sisters of women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Insulin, insulin-like growth factor I (IGF-I) and IGF-II enhance basal and gonadotrophin-releasing hormone-stimulated luteinizing hormone release from rat anterior pituitary cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Clinical and Hormonal Effects of Chronic Gonadotropin Releasing Hormone Agonist Treatment in Polycystic Ovarian Disease*

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Prenatal androgens alter GABAergic drive to gonadotropin-releasing hormone neurons: implications for a common fertility disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Effect of sex steroids on beta-endorphin in hypophyseal portal blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Luteinizing hormone and follicle stimulating hormone secretion patterns in girls throughout puberty measured using highly sensitive immunoradiometric assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Ontogeny of pulsatile gonadotrophin secretion and pituitary responsiveness in male puberty in man: a mixed longitudinal and cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Inappropriate Secretion of Follicle-Stimulating Hormone and Luteinizing Hormone in Polycystic Ovarian Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

A chronobiologic abnormality in luteinizing hormone secretion in teenage girls with the polycystic-ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML017

Prevalence and trends in overweight among US children and adolescents, 1999-2000

21 January 2018

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1001/JAMA.288.14.1728

Identifiers

DOI

10.1093/HUMUPD/DML017

1 reference

21 June 2017

1 reference